Get startedLog in
    Picture of Apogee Therapeutics logo

    APGE — Apogee Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Abbvie jumps after $10.9 billion deal to buy Apogee Therapeutics

    Picture of Apogee Therapeutics logoApogee Therapeutics
    22/06/2026 17:34
    BUZZ-Abbvie jumps after $10.9 billion deal to buy Apogee Therapeutics
    • Shares of biotech firm Abbvie ABBV.N  up 6.8% at $231.1
    • Abbvie to acquire drug developer Apogee Therapeutics APGE.O for $10.9 billion in cash
    • Apogee shareholders will receive $135.11 per share in cash
    • Deal expected to be accretive to ABBV's adj EPS starting 2032
    • Shares of Abbvie up 1.2% YTD, including session moves
    (Reporting by Arunesh Sinha in Bengaluru)
    ((arunesh.sinha@thomsonreuters.com))

    Recent news on Apogee Therapeutics

    See all news